Morning Briefing
Summaries of health policy coverage from major news organizations
Novartis To Buy GlaxoSmithKline's Oncology Unit
The deal, worth billions, will also see Novartis sell its vaccines unit to Glaxo and partner with Glaxo on their consumer divisions. Novartis also said it will sell its animal health division to Eli Lily.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
